USPTO serial 98332305
TOOLGEN
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- KOPENSKI, CLAUDIA ANN
- Law office
- TMO LAW OFFICE 129
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TOOLGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700DENVER, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of hereditary diseases; veterinary preparations for the treatment of hereditary diseases; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for use in testing genetic mutation in prion genes for medical purposes; stem cells for medical purposes; biotechnological preparations for medical purposes for the treatment of hereditary diseases, namely, pharmaceutical preparations for the treatment of hereditary diseases; cells for medical purposes; diagnostic preparations for medical purposes; cultures of microorganisms for medical purposes; cultures of microorganisms for veterinary purposes; diagnostic preparations for veterinary purposes; biological preparations for medical or veterinary purposes for the treatment of hereditary diseases; surgical implants grown from stem cells; sanitary preparations for medical use | ACTIVE | — |
| 042 | Scientific consultation and providing scientific information in the field of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; analysis of amino acid for medical research purpose; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; structural and functional analysis of genomes; multiple nucleotide sequence analysis for scientific research purposes; scientific research in the fields of biology; consultation and providing information in the fields of biology; laboratory research in the field of biology; genetic testing for scientific research purposes; gene analysis for scientific research purposes; drug discovery services; protein analysis for scientific research purposes; stem cell testing for medical research purposes; research and development in the pharmaceutical fields; research and development in the biotechnology fields; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA screening for scientific research purposes; research and development of DNA chips; biotechnology research; biological research; research and development of new products for others; research on the subject of pharmaceuticals; bacteriological research | ACTIVE | — |
| 044 | Medical services and health care services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of gene therapy for medical treatment purposes; genetic counseling for medical purposes; medical diagnostic services; medical services, namely, physical examination services; performing diagnosis of diseases; medical services relating to the removal, treatment and processing of stem cells; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; analysis of human biodata for medical purposes; medical pathology for the diagnosis and treatment of disease; plant nursery services; animal breeding; analysis of human tissues for medical treatment; medical consultation and providing medical information in the field of biomedicine; multiple nucleotide sequence analysis for medical diagnostic purposes; stem cell testing for medical treatment, and diagnosis; gene analysis for medical diagnostic purposes; consultation and providing information in the fields of medicine and health for medical treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 31, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 30, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 29, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 28, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 24, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 14, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 23, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 23, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 23, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 8, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |